Therefore, the SphK–S1P–S1PR axis has attracted attention as a therapeutic target for various diseases such as cancer, rheumatoid arthritis, diabetes mellitus, and osteoporosis [12,13]. This evidence concerns the gene MBTPS1 and cancer.